Guosen Pharmaceutical is a CRO company engaged in pharmaceutical R&D and clinical research, focusing on providing overall solutions for clinical research services and registration declarations for drugs, biological products, and medical devices. The company recently announced the completion of nearly 100 million yuan in B+ round financing. In this round of financing, the old shareholder Yueyin Medical Fund continued to increase its stake. At the same time, well-known investment institutions in the industry Guangzhou High-tech Zone Group Guangzhou Guoju Venture Capital, Shenzhen Qianhai Beizeng Assets, Zhongguancun Bank Technology Finance Center, and Ruize (Guangzhou) Investment jointly invested.
This article is transferred from: https://www.itjuzi.com/investevent/13715526
This site is only for collection, and the copyright belongs to the original author.